About the Authors
- Carmen Parola
-
Contributed equally to this work with: Carmen Parola, Laura Salogni, Xenia Vaira
Affiliation Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy
- Laura Salogni
-
Contributed equally to this work with: Carmen Parola, Laura Salogni, Xenia Vaira
Affiliation Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy
- Xenia Vaira
-
Contributed equally to this work with: Carmen Parola, Laura Salogni, Xenia Vaira
Affiliation Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy
- Sara Scutera
-
Affiliation Dept. Public Health and Pediatric Sciences, Università degli Studi di Torino, Torino, Italy
- Paolo Somma
-
Affiliation Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy
- Valentina Salvi
-
Affiliation Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy
- Tiziana Musso
-
Affiliation Dept. Public Health and Pediatric Sciences, Università degli Studi di Torino, Torino, Italy
- Giuseppe Tabbia
-
Affiliation Pulmonary Division, Ospedale S. Giovanni Battista, Torino, Italy
- Marco Bardessono
-
Affiliation Pulmonary Division, Ospedale S. Giovanni Battista, Torino, Italy
- Christian Pasquali
-
Affiliation Preclinical Research, OM Pharma SA, Meyrin 2/Geneva, Switzerland
- Alberto Mantovani
-
Affiliations Humanitas Clinical and Research Center, Rozzano, Italy, Dept. Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano, Italy
- Silvano Sozzani
-
Affiliations Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy, Humanitas Clinical and Research Center, Rozzano, Italy
- Daniela Bosisio
-
* E-mail: bosisio@med.unibs.it
Affiliation Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy
Competing Interests
The authors have read the journal's policy and have the following financial conflict: this work was partially funded by Viforpharma, who initially took part in general research planning. The authors also declare that one of the authors, namely Dr. Christian Pasquali, is affiliated to OM Pharma SA, the commercial company that produces and sells OM-85. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DB AM SS. Performed the experiments: C. Parola LS XV SC PS VS TM. Analyzed the data: C. Parola LS PS VS TM DB. Contributed reagents/materials/analysis tools: GT MB C. Pasquali. Wrote the paper: SS DB.